コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 oding the vaccinia virus F17 protein and the cowpox A-type inclusion protein are known to possess seq
4 ass I-like protein (OMCP) is conserved among cowpox and monkeypox viruses, secreted by infected cells
5 es, notably, vaccinia virus (VACV), but also cowpox and myxoma viruses, are able to evade host IFN re
11 Zika, Ebola, Sindbis, vesicular stomatitis, cowpox, and vaccinia, but not murine leukemia or adenovi
16 including viruses that produce ATIs, such as cowpox, ectromelia, and raccoonpox viruses, as well as t
18 different strains and isolates of camelpox, cowpox, ectromelia, gerbilpox, herpes, monkeypox, myxoma
19 , we used recombinant VACVs that express the cowpox full-length ATIp or we transfected plasmids encod
20 for the prodrugs (<0.1-50 muM) vs vaccinia, cowpox, human cytomegalovirus, and herpes simplex type 1
21 induce apoptosis from studies utilizing the cowpox ICE inhibitor protein CrmA, the synthetic tetrape
22 inhibitor of complement enzymes (SPICE), and cowpox inflammation modulatory protein (IMP) were simila
24 hopoxviruses, including vaccinia, rabbitpox, cowpox, monkeypox, camelpox and variola viruses, deploy
25 an orthopoxviruses (OPV): variola, vaccinia, cowpox, monkeypox, camelpox, ectromelia, and taterapox v
31 optotic pathway is potently inhibited by the cowpox serpin CrmA, suggesting that Mch5 could be the ta
32 The crmD gene was interrupted in three other cowpox strains examined and absent in various other orth
33 , and other protease inhibitors, such as the cowpox viral serine protease inhibitor, CrmA, and N-alph
36 owever, CD8(+) T cells of mice infected with cowpox virus (CPV) or VV recognized APC infected with VV
37 sential for full virulence and, like crmA of cowpox virus (CPV), is reported to inhibit the interleuk
39 en, we identified a viral inhibitor found in cowpox virus (CPXV) and other orthopoxviruses that bound
40 port that the secreted M2 protein encoded by cowpox virus (CPXV) specifically interacts with human an
42 nfectious Rift Valley fever virus (RVFV) and cowpox virus (CPXV) was also not affected by BST-2 expre
43 ses like variola virus, monkeypox virus, and cowpox virus (CPXV), but not vaccinia virus, encode a un
48 he 204-bp amplicon allowed discrimination of cowpox virus (melting temperature [T(m)], 56.40 degrees
49 (m)s, 61.9 to 62.2 degrees C), 40 strains of cowpox virus (T(m)s, 61.3 to 63.7 degrees C), 8 strains
50 egulate inflammation (myxoma virus SERP1 and cowpox virus [CPV] crmA/SPI-2) or apoptosis (myxoma viru
51 by either late (the AmEPV spheroidin or the cowpox virus A-type inclusion [ATI]) or early (the AmEPV
53 derate activities (EC(50) 39 microM) against cowpox virus and severe acute respiratory syndrome coron
57 esolution crystal structure of OMCP from the cowpox virus Brighton Red strain, revealing a truncated
62 an and mouse SAMD9&L, it can be inhibited by cowpox virus CP77, indicating that OPXVs encode three SA
63 deletion in the CPXV012 gene in an ancestral cowpox virus created the current form of CPXV012 that is
66 a recombinant fusion protein comprised of a cowpox virus encoded NKG2D binding protein (OMCP) and a
69 ineering this change back into the wild-type cowpox virus genome conferred resistance to ST-246, sugg
71 gion of the genome that is type-specific for cowpox virus identified a gene, vCD30, encoding a solubl
72 The efficacy of cidofovir for treatment of cowpox virus infection in BALB/c mice was investigated i
75 irst known human case of laboratory-acquired cowpox virus infection in the United States and the ensu
78 nal A26p, determined by complementation of a cowpox virus occlusion-defective mutant, its role in occ
85 combinant region consistent with a strain of cowpox virus stored in the research laboratory's freezer
91 t orthopox viruses (smallpox, monkeypox, and cowpox virus) of the synthesized nucleosides are describ
93 bUL49.5 (bovine herpesvirus 1), and CPXV012 (cowpox virus), assembling a structural atlas of viral TA
96 ng extreme vulnerability to monkeypox virus, cowpox virus, and vaccinia virus and thus providing a un
98 response modifier A (CrmA), a product of the cowpox virus, prevents programmed cell death initiated b
99 structure to 1.85-A resolution of vCCI from cowpox virus, the prototype of this poxvirus virulence f
101 DN) caspase-8, cytokine response modifier A (cowpox virus-encoded antiapoptotic protein), or DN Fas-a